Innovating Rare Disease Treatment: Integrating Digital Tools from Day One

How pharma, advocacy groups, and digital platforms are revolutionizing patient support

13 Mar 2025

In this webinar, UCB Pharma and the Les Turner ALS Foundation joined Medisafe discuss the integration of digital tools in innovating rare disease treatment. Below are the highlights and the full webinar:

  • The integration of digital tools in rare disease treatment can significantly streamline diagnosis and therapy initiation, offering a more personalized approach to patient care.
  • Multidisciplinary care is vital for ALS patients, involving various specialists like neurologists, pulmonologists, and occupational therapists to enhance quality of life and extend survival.
  • Patient engagement and the use of hyper-personalized digital tools can improve adherence, engagement, and ultimately patient outcomes in rare diseases.



You may also like

Webinars

RWE Impact: When Empowered Patients Drive Pharma Outcomes

Discover the transformative power of RWE and how it can can revolutionize your pharma strategy. Spefically they expert panel poke 

..Read More
Webinars

[WEBINAR]: Rare Disease Revolution: Access, Advocacy, & Amplification of the Patient Voice

Lorna Weir from Elevate Healthcare Marketing, Stacey Meltzer Wasserman from Medisafe®, as well as KJT’s Katy Palmer, PhD and Ellen 

..Read More
Webinars

Unlocking the Mystery: Data & Innovation in Women’s Health

Our recent webinar with Fierce Pharma shows how leading agencies and Medisafe are cracking the code on PCOS and other 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.